/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world s transition to sustainable consumption through.
Amyris, Inc. (NASDAQ:NASDAQ:AMRS) Q1 2022 Results Conference Call May 10, 2022 09:00 AM ET Company Participants John Melo - President and Chief Executive Officer Han Kieftenbeld - Chief.
/PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer.